Literature DB >> 18035246

Reperfusion seizures: a manifestation of cerebral reperfusion injury after administration of recombinant tissue plasminogen activator for acute ischemic stroke.

Faizan Hafeez1, Mohammad A Razzaq, Ross L Levine, Mark Allan N Ramirez.   

Abstract

Reperfusion injury has been well described in medical literature; cerebral reperfusion injury is commonly seen in association with vascular surgical procedures such as carotid endarterectomies and stent placement procedures. Cerebral reperfusion injury can manifest as blood-brain barrier breakdown, cortical irritability, and epileptic seizures. Seizures induced by cerebral reperfusion have not been documented or reported after thrombolytic therapy for acute ischemic stroke. We report a patient who received intravenous recombinant tissue plasminogen activator within 3 hours of stroke symptom onset and developed the new-onset symptom of continuous, primary motor seizure activity within 20 minutes of recombinant tissue plasminogen activator administration. These epileptic seizures originated in the same area as the acute brain ischemia and occurred during the anticipated period of cerebral reperfusion. In this article we describe a case report and then discuss the pathophysiology and mechanisms that may underlie reperfusion epileptic seizures as a manifestation of cerebral reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18035246     DOI: 10.1016/j.jstrokecerebrovasdis.2007.07.007

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  6 in total

Review 1.  Late-onset epilepsy and occult cerebrovascular disease.

Authors:  Lorna M Gibson; Martha F Hanby; Sarah M Al-Bachari; Laura M Parkes; Stuart M Allan; Hedley C A Emsley
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-12       Impact factor: 6.200

2.  Cortical myoclonus during IV thrombolysis for ischemic stroke.

Authors:  Carla Bentes; Rita Peralta; Pedro Viana; Carlos Morgado; Teresa P Melo; José M Ferro
Journal:  Epilepsy Behav Case Rep       Date:  2014-10-16

3.  2-(2-Benzofuranyl)-2-imidazoline treatment within 5 hours after cerebral ischemia/reperfusion protects the brain.

Authors:  Zheng Zhang; Jin-Long Yang; Lin-Lei Zhang; Zhen-Zhen Chen; Jia-Ou Chen; Yun-Gang Cao; Man Qu; Xin-Da Lin; Xun-Ming Ji; Zhao Han
Journal:  Neural Regen Res       Date:  2018-12       Impact factor: 5.135

4.  Risk Factors for Epilepsy After Thrombolysis for Ischemic Stroke: A Cohort Study.

Authors:  Rosane Brondani; Andrea Garcia de Almeida; Pedro Abrahim Cherubini; Thaís Leite Secchi; Marina Amaral de Oliveira; Sheila Cristina Ouriques Martins; Marino Muxfeldt Bianchin
Journal:  Front Neurol       Date:  2020-01-23       Impact factor: 4.003

5.  Association between different acute stroke therapies and development of post stroke seizures.

Authors:  Jillian Naylor; Arthur Thevathasan; Leonid Churilov; Ruibing Guo; Yunyun Xiong; Miriam Koome; Ziyi Chen; Ziyuan Chen; Xinfeng Liu; Patrick Kwan; Bruce C V Campbell
Journal:  BMC Neurol       Date:  2018-05-03       Impact factor: 2.474

6.  Seizures after Ischemic Stroke: A Matched Multicenter Study.

Authors:  Carolina Ferreira-Atuesta; Nico Döhler; Barbara Erdélyi-Canavese; Ansgar Felbecker; Philip Siebel; Natalie Scherrer; Giulio Bicciato; Juliane Schweizer; Lucia Sinka; Lukas L Imbach; Mira Katan; Laura Abraira; Estevo Santamarina; José Álvarez-Sabín; Michael Winklehner; Tim J von Oertzen; Judith N Wagner; Gian Luigi Gigli; Anna Serafini; Francesco Janes; Giovanni Merlino; Mariarosaria Valente; Giorgia Gregoraci; Julian Conrad; Stefan Evers; Piergiorgio Lochner; Frauke Roell; Francesco Brigo; Carla Bentes; Ana Rita Peralta; Teresa Pinho E Melo; Mark R Keezer; John S Duncan; Josemir W Sander; Barbara Tettenborn; Matthias J Koepp; Marian Galovic
Journal:  Ann Neurol       Date:  2021-09-30       Impact factor: 11.274

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.